Paper Details

  1. Home
  2. Paper Details

Management of Acute Myeloid Leukemia (AML) in Older Patients.

Author: AbdallahMaya, LohKah Poh, ManognaDharmini, MendlerJason H, ReadyAudrey, XieZhuoer

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This review focuses on treatment decisions for older adults with acute myeloid leukemia (AML), a type of blood cancer. It highlights the challenges faced by older patients and summarizes current treatment options, including recently approved therapies.
Paper Details　
Original Abstract of the Article :
The acute myeloid leukemia (AML) treatment landscape has rapidly evolved over the past few years. These changes have several implications for the care of older adults (≥ 60 years), who have inferior clinical outcomes. We review decision-making in older adults, focusing on patient- and disease-relate...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/32725515

データ提供：米国国立医学図書館（NLM）

Navigating the Shifting Sands of AML Treatment for Older Adults

Acute myeloid leukemia (AML) is a serious condition, and for older adults, it can be especially challenging. This study, published in [Journal Name], delves into the complexities of AML treatment for older adults. It's like exploring a desert landscape with unique challenges and opportunities. This review discusses decision-making in older adults with AML, considering both patient- and disease-related factors. It also summarizes current treatment options, including newly approved therapies, based on hypothetical clinical scenarios. The authors highlight the need for tailored approaches to address the specific needs of older adults with AML, acknowledging the challenges and opportunities presented by this age group. It's like mapping out a specific route through the desert, considering the unique features of the terrain and the resources available.

AML Treatment: Tailoring the Approach for Older Adults

The study underscores the importance of individualized care for older adults with AML. The researchers emphasize that treatment decisions should be made on a case-by-case basis, taking into account factors such as age, overall health, and the specific characteristics of the AML. It's like customizing a camel caravan to suit the specific needs of each journey.

AML Treatment: A Journey Through the Desert

This study offers a valuable framework for understanding the challenges and opportunities in AML treatment for older adults. It provides a comprehensive overview of treatment options and highlights the importance of tailoring approaches to individual needs.

Dr.Camel's Conclusion

AML treatment for older adults presents a complex landscape. This study serves as a helpful guide, emphasizing the importance of individualized care, tailored treatment approaches, and ongoing research to improve outcomes for this vulnerable population. It's like navigating a desert landscape, where understanding the terrain and having the right tools can lead to successful journeys.

Date :
  1. Date Completed 2021-08-30
  2. Date Revised 2022-07-16
Further Info :

Pubmed ID

32725515

DOI: Digital Object Identifier

NIHMS1679806

Related Literature

Article Analysis
・Effects of glasdegib
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.